TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T29500	Adrenergic receptor alpha-1B	D03SKR	Clonidine	Approved	2803	C9H9Cl2N3	230.09	C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl	Ki = 417000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	B4NY9P	3-[2-[4-(4-Butan-2-ylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione	Investigative	10939209	C26H31N5O2	445.6	CCC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O	Ki = 10000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	B9U5LH	3-[2-[4-(4-Butylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione	Investigative	10950355	C26H31N5O2	445.6	CCCCC1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O	Ki = 1000000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BACD03	N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-5,6-dihydro-4H-1,3-oxazin-2-amine	Investigative	44314200	C14H18N2O	230.31	C1CC(C2=CC=CC=C2C1)NC3=NCCCO3	Ki = 148000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BES17Q	Rilmenidine	Investigative	68712	C10H16N2O	180.25	C1CC1C(C2CC2)NC3=NCCO3	Ki = 46800000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BQ5DH3	2-(1,2,3,4-Tetrahydro-1-naphthylamino)-2-oxazoline	Investigative	218362	C13H16N2O	216.28	C1CC(C2=CC=CC=C2C1)NC3=NCCO3	Ki = 407000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BT06HN	N-(2-Oxazolin-2-yl)cycloheptanamine	Investigative	294234	C10H18N2O	182.26	C1CCCC(CC1)NC2=NCCO2	Ki = 35500000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BWSV21	3-[2-[4-(4-Cyclohexylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione	Investigative	10863664	C28H33N5O2	471.6	C1CCC(CC1)C2=CC=C(C=C2)N3CCN(CC3)CCN4C(=O)C5=C(C6=CC=CC=C6N5)NC4=O	Ki = 1E+27 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BY38LJ	N-[(2S)-2-Propylcyclohexyl]-4,5-dihydro-1,3-oxazol-2-amine	Investigative	44314198	C12H22N2O	210.32	CCC[C@H]1CCCCC1NC2=NCCO2	Ki = 251000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BY4Z3Q	4-(4,5-Dihydro-1,3-oxazol-2-yl)morpholine	Investigative	21392988	C7H12N2O2	156.18	C1COC(=N1)N2CCOCC2	Ki = 1000000000000 nM	Non binder
T29500	Adrenergic receptor alpha-1B	BZ65QT	3-[2-[4-(4-Tert-butylphenyl)piperazin-1-yl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione	Investigative	11762075	C26H31N5O2	445.6	CC(C)(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O	Ki = 100000000000 nM	Non binder